Anticholesteremic property of Lactobacillus acidophilus yogurt fed to mature boars

Three strains of Lactobacilus acidophilus (LA) were isolated from the feces of mature boars that were not being fed antibiotics from the Nebraska Gene Pool (NGP). All three LA isolates were screened in vitro for anticholesteremic and antimicrobial activities. One strain, LA16, caused the greatest reduction in cholesterol and inhibited both Bacillus subtilis and Escherichia coli the most. LA16 was used to produce 16, 18.9-liter quantities of acidophilus yogurt (AY), over a period of 8 wk, for use as a feed ingredient in diets for the NGP boars. Colony forming units (cfu), pH, protein, energy, Ca and P were consistent across all 16 batches of yogurt. All of the 18 boars were fed a high-cholesterol diet for a period of 56 d at a rate of 2.268 kg/(hd.d) to furnish 6.661 g/(hd.d) of cholesterol. Nine of the boars then were fed 1.81 kg/(hd.d) of a second diet that was supplemented with .454 kg/(hd.d) of AY. The other nine boars were fed the original diet. Cholesterol intake was the same for the two dietary treatments. Blood samples were collected weekly from the brachial-jugular region and the sera were analyzed for lipids. Acidophilus yogurt reduced serum cholesterol (P less than .01) and low density lipoproteins (P less than .08), but it had no effect on serum triglycerides (P greater than .23) or on high density lipoproteins (P greater than .11).

Effect of exogenous thyroxine on the interval from weaning to estrus of the primiparous sow

A total of 159 primiparous sows were fed 0 (C) or 675 mg/d of thyroprotein (TP) from d -2 until d 14 postweaning. Sows received 8 (LE) or 14 (HE) Mcal of ME/d during a 28-d lactation period. Plasma levels of 3,5,3'-triiodothyronine (T3) and 3,5,3',5'-tetraidothyronine (T4) were determined for d -4, -2, 0, 1, 2, 3, 5 and 7 postweaning. Sows consuming LE lost more weight and backfat during lactation (P less than .01) than HE sows. Litters of sows consuming LE gained less weight than litters of sows consuming HE (P less than .01). Thyroprotein increased plasma levels of both T3 and T4 (P less than .01), whereas energy intake had no effect (P greater than .10) on either of the two hormones. The response to thyroid hormone was not consistent across days postweaning (TP x day, P less than .01). Feeding TP increased T4 (P less than .01) on all days, and T3 was increased (P less than .05) on d 0, 2 and 3 postweaning. Thyroid hormones rose markedly following weaning regardless of TP level. Percentage of sows in estrus by d 7 postweaning for LE-C, LE-TP, HE-C and HE-TP were 80, 78, 92 and 90, respectively. Energy restriction during lactation resulted in fewer sows returning to estrus by d 7 (P less than .03) than those fed HE. However, feeding TP postweaning had no effect on return to estrus, suggesting that the effect of dietary energy restriction during lactation on the interval from weaning to first estrus is not mediated through postweaning thyroid hormone concentrations.

Reversible myocardial damage in gerbil brain ischaemia and its prevention by beta-adrenergic blockade

Acute cerebral infarction in gerbils, produced by unilateral carotid ligation, was used as a model to investigate secondary myocardial changes. The extent of the myocardial damage revealed by succinic dehydrogenase (SDH) histochemistry and by release of myocardial creatine phosphokinase (MB-CK) was measured in gerbils sacrificed from 3 to 48 h after either carotid ligation, carotid isolation only or skin incision only. For technical reasons dead animals were excluded from analysis. Of surviving ligated animals 74% developed neurological deficits related to brain ischaemia. A significant weight increase in the ipsilateral hemisphere was found at 6-10 h, and maximal histological damage at 16 h, both partially reversible thereafter. Non-ligated animals did not develop neurological changes, and showed neither brain swelling nor cerebral histopathology. Extensive cardiac damage was shown by the SDH method from 3 h postoperatively, and confirmed by the elevated serum levels of MB-CK in the carotid-ligated group. The SDH changes were identical with those described in the hearts of patients with acute intracranial lesions, and appeared to be reversible. The effect of beta-adrenergic blockade was assessed in this model. Metoprolol tartrate injected intraperitoneally 3 h before and 1 h after carotid ligation (10 mg/kg each dose) significantly decreased the extent of myocardial damage as estimated both with SDH histochemistry and MB-CK serum levels. It had no effect on the ischaemic brain changes. These results strongly support the concept of catecholamine mediation of myocardial injury resulting from acute brain lesions.

The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases

Neuropathologic confirmation is required to validate the NINCDS-ADRDA Work Group criteria for the clinical diagnosis of Alzheimer's disease (AD). Neuropathologic inclusion and exclusion criteria for AD, however, are not uniform. The purpose of this investigation was to examine the confirmation rate for the Work Group criteria against differing neuropathologic criteria for AD. The sample consisted of 57 cases, 22 of which had received a clinical diagnosis of AD. Nine neuropathologic criteria for AD were applied in a blind fashion to each of the 57 cases. Our results indicated that, depending on the neuropathologic criteria applied, the clinicopathologic agreement ranged from 64% to 86%. These findings demonstrate the need for universally accepted neuropathologic and clinical criteria for AD.

Sarcoma metastatic to the brain

Five patients with nonlymphomatous sarcoma metastatic to the brain are presented and the literature reviewed. In 50 patients, brain metastasis was verified pathologically and some case data were available, including the five reported here. In five patients, there was pathologic verification but no case data. Thirty-nine other patients were found without such verification. Reportedly, most types of sarcomas are able to metastasize to the brain, and are represented in these 94 patients. Fibrosarcoma and alveolar soft-part sarcoma tumors metastasize to the brain without regard to treatment technique. There may be a group of tumors, including malignant fibrous histiocytoma, rhabdomyosarcoma, and perhaps leiomyosarcoma and osteosarcoma, in which the incidence of brain metastases has increased with improved sarcoma chemotherapy (CT). In this group particularly, but also in alveolar soft-part sarcoma and others, the presence of lung metastases may increase the probability of brain metastasis occurring subsequently.

Do anti-allergic drugs or anticholinergic drugs have a role in the treatment of asthma?

After the successful introduction of sodium cromoglycate (SCG) for the treatment of asthma, emphasis was placed on its apparent novel mechanism of action, the inhibition of inflammatory mediator release from mast cells. This opened the flood gates for numerous SCG-derivatives, many with oral efficacy and improved potency. The majority of these compounds were ineffective clinically, casting doubts on SCG's mechanism of action and questioning the importance of mast cells in asthma. However, information on the heterogeneity of mast cells has directed recent drug screening to new, more relevant models of asthma involving other inflammatory cells. Consequently, nedocromil sodium has emerged to perhaps lead a new generation of antiallergic drugs. Bronchodilator anticholinergic drugs have met with a resurgence of interest of late with the development of a number of quaternary ammonium homologues of atropine. While not as effective as beta-adrenoceptor agonists in asthma they are particularly effective in chronic obstructive pulmonary disease. Drugs with anticholinergic properties and associated beneficial effects are also under investigation.

Phenylephrine derivatives as leukotriene D4 antagonists

Two series of phenylephrine derivatives were prepared and tested as inhibitors of leukotriene D4 (LTD4) induced and ovalbumin-induced bronchospasm in the guinea pig. The most potent compound of the urea series, (R)-N,N-diethyl-N-[2-hydroxy-2-[3-(2-quinolinylmethoxy)phenyl]ethyl]-N- methylurea (3, Wy-47,120), was orally active with ED50's of 56 mg/kg vs. LTD4 and 55 mg/kg vs. ovalbumin. When tested as an antagonist of LTD4-induced contraction of isolated guinea pig tracheal strips, 3 was a competitive inhibitor with a p kappa B value of 5.22. In the second series, (R)-3-methyl-5-[3-(2-quinolinylmethoxy)phenyl]-2-oxazolidinone (26, Wy-47,674) had oral ED50's of 36 mg/kg against LTD4 and 95 mg/kg against ovalbumin. Compound 26 selectively antagonized contractile responses of guinea pig trachea evoked by LTD4 (p kappa B = 6.09). In the cat coronary artery, 3 dilated the preparation and blocked the coronary constrictor effect of LTD4. Compound 3 (0.13 mg/kg, iv) also preserved myocardial integrity in rats 48 h after coronary artery ligation. When tested in the rat alcohol-induced gastric lesion model, 3 and 26 manifested a dose-dependent mucosal protection against ethanol.

Effect of zinc source and picolinic acid on 65Zn uptake in an in vitro continuous-flow perfusion system for pig and poultry intestinal segments

Twenty weanling pigs and fourteen 9-wk-old broiler chickens were used in three continuous-flow in vitro perfusion experiments using noneverted intestinal sacs to 1) determine differences in 65Zn absorption due to location within the intestinal tract, 2) evaluate 65Zn uptake from ZnCl2 and Zn-methionine (ZnMet) with or without added picolinic acid (PA) in pig intestinal sacs and 3) evaluate 65Zn uptake from ZnCl2 and ZnMet in chicken intestinal sacs. No differences in 65Zn uptake due to gut segment position were observed in the pigs. A Zn source x PA interaction was observed for 65Zn uptake into the pig gut tissue and for 65Zn uptake to the serosal side of the gut sacs. Total 65Zn absorption in the pig gut sacs from the two Zn sources was not different, but the addition of a 5 M ratio of PA to Zn depressed 65Zn absorption. No differences were observed in total 65Zn absorption or 65Zn uptake in poultry gut sac tissue. There was, however, greater uptake of 65Zn from ZnCl2 to the serosal side of the sacs than from ZnMet. The data indicate that 65Zn from ZnCl2 and ZnMet is similar in total absorption and that the addition of PA depresses Zn uptake.

Influence of picolinic acid on the uptake of 65zinc-amino acid complexes by the everted rat gut

Three hundred fifty rats were used in three experiments to: 1) validate the everted gut procedure as an in vitro technique for estimating Zn absorption, 2) determine the effect of increasing ratios of picolinic acid (PA) to Zn on Zn absorption and 3) determine the effect of PA on absorption of Zn and amino acid complexes at pH 6, 7 and 8. In the first experiment the time delay between tissue collection with subsequent storage in ice-cold saline and start of tissue incubation was 0, 10, 20 or 30 min. A linear decrease was observed for 65Zn uptake with increasing delay time. Lysine absorption was not affected by delay time. In the second experiment, molar ratios of PA:Zn of 0, .5, 1.0, 1.5, 2.0 and 2.5 with Zn held constant were evaluated. A linear decrease in 65Zn absorption from 65ZnCl2 occurred as the molar ratio of PA to Zn increased. In the third experiment, 0 and 5 molar ratios of PA to a constant Zn level were evaluated using 65ZnCl2, 65Zn-14C-methionine (ZnMet) and 65Zn-3H-lysine (ZnLys) at pH 6, 7 and 8. The addition of PA decreased Zn absorption regardless of Zn source. The data suggest that the Zn sources used were of similar biological value. The data do not support the theory that PA facilitates Zn absorption.

Effect of protein and energy intake by primiparous sows during lactation on sow and litter performance and sow serum thyroxine and urea concentrations

The effects of protein and energy intakes by primiparous sows during a 28-d lactation on thyroxine (T4) and urea concentrations in blood serum of sows, and sow and litter performance were examined in two experiments. Dietary treatments were protein intakes of 380 (LP) and 760 (HP) g of crude protein X sow-1 X d-1 and energy intakes of 8 (LE) and 16 (HE) Mcal of metabolizable energy (ME) X sow-1 X d-1 in a 2 X 2 factorial arrangement. In Exp. 1 (34 sows), neither protein nor energy intake affected serum T4 concentrations. In both experiments, serum urea concentrations during lactation were influenced by both protein (P less than .001) and energy (P less than .001) intakes. In Exp. 2 (221 sows), sows fed LP or LE lost more weight (P less than .001) during lactation than sows fed either HP or HE. Backfat loss was greater (P less than .001) in sows fed diets of LE than HE, whereas sows fed HP lost more backfat (P = .016) than sows fed LP. Pig weights on d 28 were influenced by both protein (P less than .001) and energy (P = .038), with sows that were provided high intakes of either protein or energy having heavier pigs. Litter weight at weaning was heavier (P less than .005) for sows consuming HP. Sows fed LP had larger litters at d 14 (P = .051) and 28 (P = .046) than sows fed HP. Sow energy intake had no effect on litter size or weight. Percentages of sows in estrus by 7, 14 and 35 d postweaning were higher (P less than .004, P less than .030 and P less than .060, respectively) for sows fed HP than LP, whereas sow energy intakes had no effect on the interval from weaning to first estrus.

Chronic regenerative changes in the spinal cord after cord compression injury in rats

Long-term regenerative changes and pathological effects after acute compression injury of the spinal cord were studied in rats. Twenty adult female Wistar rats underwent cord injury by the extradural clip compression technique at T6-7. Following injury, extradural electrodes attached to receiver-stimulators that were implanted subcutaneously were placed proximal and distal to the injury site. The animals were maintained in cages with electromagnetic fields created by encircling antennae. The control animals were in a field adjusted to a frequency below the sensitive frequency range of the receiver-stimulators so that they received no spinal cord stimulation. After 15-20 weeks of continuous spinal cord stimulation, histological sections of the cords were assessed and scored blindly for pathological changes including magnitude and extent of cord injury, and cystic cavitation, and for regenerative changes including proliferation of axons, Schwann cells and ependymal cells, and formation of myelin. In all 20 animals, there was a complete absence of normal cord tissue at the injury site, and cystic cavitation was frequently present at the injury site and beyond. Extensive regenerative changes were seen in all animals including regeneration of axons, Schwann cells and ependymal cells, and formation of myelin. Statistical analysis did not show a significant difference between treatment and control groups.

Leukotriene D4 antagonists and 5-lipoxygenase inhibitors. Synthesis of benzoheterocyclic [(methoxyphenyl)amino]oxoalkanoic acid esters

A series of novel benzoheterocyclic [(methoxyphenyl)amino]oxoalkanoic acid esters has been prepared. These compounds were tested as inhibitors of rat polymorphonuclear leukocyte 5-lipoxgenase (LO) in vitro and as inhibitors of leukotriene D4 (LTD4) and ovalbumin (OA) induced bronchospasm in the guinea pig (GP) in vivo. In general, inhibitory activity against 5-LO, LTD4, and OA was broadest for benzthiazole-containing analogues (benzthiazole greater than benzimidazole much greater than benzoxazole, benzofuran). The most potent 5-LO inhibitor, 4-[[3-(2-benzthiazolylmethoxy)-phenyl]hydroxyamino]-4-oxobutanoic acid methyl ester (7), had an IC50 of 0.36 microM. Compound 7, however, was inactive vs. OA. The most potent compound in vivo, 4-[[3-[(1-methyl-2-benzimidazolyl)methoxy]phenyl]-amino] -4-oxobutanoic acid methyl ester 4, inhibited both LTD4- and OA-induced bronchospasm by 83% and 60%, respectively, at 50 mg/kg intraduodenally. Compound 4 was studied in the Ames assay employing five strains of bacteria (TA1535, TA1537, TA1538, TA98, and TA100) with and without S-9 rat liver enzyme metabolic activation, and there was no significant number of reversions noted.

Effects of thiazinamium chloride and other antihistamines on phosphatidylcholine secretion in rat type II pneumocyte cultures

Thiazinamium chloride (TCl) stimulated phosphatidylcholine secretion in cultures of adult rat type II pneumocytes in a concentration-dependent manner in the range 10(-9)-10(-6) M. At the optimal concentration, secretion was stimulated by 46% which is approximately half the stimulatory effect of the beta-agonists terbutaline and isoproterenol. TCl did not increase the rate of choline incorporation into cellular phosphatidylcholine or of lactate dehydrogenase release so its effect on secretion was not secondary to phosphatidylcholine synthesis or cell injury. Since TCl has antihistaminic properties, we examined the effects of other antihistamines. The H-1 antagonists promethazine, which is structurally similar to thiazinamium, and pyrilamine, which has a different structure, also stimulated secretion but the H-2 antagonist, cimetidine, did not. The effects of TCl and pyrilamine were additive to those of terbutaline, suggesting that the mechanisms of action of the antihistamines and the beta-agonist were different. Although we were unable to demonstrate an inhibitory effect of histamine itself on either basal or terbutaline-stimulated phosphatidylcholine secretion, it is possible that histamine plays a regulatory role in lung surfactant secretion.

Inhibition of leukotriene-induced contraction of guinea pig trachea by 5-lipoxygenase inhibitors

The effects of the 5-lipoxygenase inhibitors nordihydroguiaretic acid (NDGA), 5, 8, 11, 14-eicosatetraynoic acid (ETYA), 1-phenyl-3-pyrazolidone (phenidone) and BW-755c, on the contractile response to LTC4 or LTD4 were examined on the isolated guinea pig trachea. Responses to either LTC4 or LTD4 were obtained on indomethacin treated tissues, in the presence of either L-serine-borate complex or L-cysteine, respectively, to inhibit metabolic conversion of the leukotrienes. NDGA (30 microM) and ETYA (100 microM) produced a selective competitive antagonism of LTD4-induced contractions, while phenidone antagonized both LTC4- and LTD4-induced responses in a non-competitive manner. In contrast, BW-755c (30 microM) did not significantly antagonize LTC4 or LTD4 concentration-response curves. The results suggest that leukotriene antagonism may be produced by large concentrations of some 5-lipoxygenase inhibitors.

Immunological abnormalities in rats with adjuvant-induced arthritis--II. Effect of antiarthritic therapy on immune function in relation to disease development

The effects of the experimental immunomodulatory agent tilomisole (Wy-18,251; (3-(p-chlorophenyl) thiazolo [3,2-a]benzimidazole-2-acetic acid) on disease development and immune function in rats with adjuvant-induced arthritis was assessed in comparison with indomethacin and levamisole. Daily p.o. administration of tilomisole (100-200 mg/kg/day) to M. butyricum-injected rats significantly reduced both edema and bone erosion in the uninjected paw. Moreover, tilomisole treatment restored to normal the diminished Con A-induced proliferative response and IL 2 synthesis observed in spleen cells from arthritic rats, but had no effect on macrophage IL 1 production. In contrast, levamisole treatment (25 mg/kg/day) of arthritic rats improved splenic immune function but did not influence paw edema or bone erosion. Conversely, indomethacin (1 mg/kg/day) significantly reduced paw edema and bone erosion but did not improve the deficient proliferative response or IL 2 synthesis by "arthritic" spleen cells. These results indicate that tilomisole possesses combined antiinflammatory and immunomodulatory activity in adjuvant-arthritic rats which is distinctly different from the effects of either indomethacin or levamisole. Moreover, these data suggest that tilomisole has potential disease-modifying activity in arthritis, which is currently being more closely examined in clinical trials.

Effect of dietary fluorine on growth, blood and bone characteristics of growing-finishing pigs

Three hundred eighty-four growing-finishing pigs were used in two experiments to determine the effect of dietary fluorine (F) on growth, blood and bone physical characteristics. Fourteen dietary treatments were formulated by supplementing F (as NaF) to a milo-soybean meal basal diet (7 ppm F) to provide levels of 7, 132, 257, 382, 507 and 632 ppm F for Exp. 1, and 7, 25, 43, 61, 79, 97, 115 and 133 ppm F for Exp. 2. Average daily gain (ADG) and average daily feed intake (ADFI) were not affected (P greater than .09) when F was fed at levels between 7 and approximately 132 ppm. Average daily gain and ADFI were reduced (P less than .0001) for pigs consuming diets with F concentrations greater than 132 ppm (Exp. 1). Feed conversion was not affected (P greater than .17) by any level of F fed. Serum F and alkaline phosphatase concentrations increased (P less than .01) with increasing dietary F levels. Serum and bone Ca and P concentrations were not affected (P greater than .13) by dietary F levels (Exp. 1). In Exp. 1 and 2, bone F increased (P less than .0001) and metatarsal stress and modulus of elasticity decreased (P less than .0001) as level of F increased in the diet. Bone thickness decreased quadratically (P less than .02) in Exp. 1 and linearly (P less than .0007) in Exp. 2 with increased dietary F levels. Scanning electron microscopy showed an increase in porosity of bones from pigs fed the higher levels of F. Growing-finishing pigs were able to tolerate approximately 132 ppm F for growth, but all of the F levels (greater than or equal to 7 ppm) fed in these two experiments affected bone integrity.

Synthesis and antiallergic activity of a novel series of 5-lipoxygenase inhibitors

A series of novel substituted [[(phenoxymethyl)phenyl]amino]oxoalkanoic acid esters have been synthesized. These compounds were tested in vitro for their ability to inhibit the synthesis of 5-hydroxyeicosatetraenoic acid and leukotriene (LT) B4 from rat polymorphonuclear leukocytes (PMN) and in vivo as inhibitors ovalbumin- (OA) and LTD4-induced bronchospasm in the guinea pig. Compounds 5-12 and 25 had IC50's between 1 and 5.6 microM in the rat PMN 5-lipoxygenase assay. Compounds 1, 3, and 16 inhibited OA-induced bronchoconstriction (61%, 64%, and 57%, respectively), but only 1 showed activity against LTD4-induced bronchoconstriction. When tested against LTD4-induced contraction of isolated guinea pig tracheal spiral strips, 1 was a competitive inhibitor with a pKB of 4.94.

Questionable role of leukotriene B4 in monosodium urate (MSU)-induced synovitis in the dog

Monosodium urate (MSU)-induced synovitis in the dog's stifle (knee joint) is similar to an acute gouty attack in man in which a loss of function of the joint correlates with massive influx of neutrophils and the release of an assortment of inflammatory mediators (e.g. histamine, bradykinin, lysosomal enzymes, complement and eicosanoids) into the synovial space. We found in the urate-induced inflammatory exudates 3 hr post MSU the following: 88 million leukocytes/ml (approximately 95% neutrophils) and eicosanoid concentrations of LTB4, LTC4, and PGE2 of less than 0.1, 1.4 and 20 ng/ml, respectively. Isotonic saline injected knee joints at 3 hr contained 5 million leukocytes/ml (approximately 95% neutrophils) and concentrations of LTB4, LTC4, and PGE2 of less than 0.1, 0.7 and 0.2 ng/ml, respectively. Intrasynovial injections of 1 microgram LTB4, 10 micrograms PGE2 or the combination of LTB4 and PGE2 produced no reduction of paw pressure for up to 3 hr. Leukocyte concentrations measured at 3 hr in joints injected with these arachidonic acids metabolites were similar to saline controls. These results question the role of LTB4 as a chemotactic and inflammatory mediator in urate-induced synovitis in the dog but confirm the importance of PGE2 and possibly LTC4 in this model.

Correlation between mouse skin inflammation induced by arachidonic acid and eicosanoid synthesis

We and others have shown that arachidonic acid (AA), when applied topically to ear surfaces, causes an intense acute inflammatory reaction within minutes (as measured by ear thickness). In this study, we have investigated the cellular and biochemical changes associated with this phenomenon and have attempted to correlate these changes with the induction of inflammation. Measurement of vascular permeability by the accumulation of [125I]albumin showed that significant plasma exudation was observed at 15 min in AA-treated ears. Furthermore, the increase in [125I]albumin was time related and was nearly 10-fold greater than control at 1 h. No time-related change in plasma exudation was observed with control ears. Measurement of LTC4 by radioimmunoassay showed that there was a significant increase in LTC4 synthesis at 15 min after AA treatment. Maximal LTC4 synthesis occurred at 15 min and subsequently decreased to 30% of peak level at 30 min. Histological examination and myeloperoxidase measurement indicated that few neutrophils were present at these early time points and suggested that cells other than neutrophils are contributing to LTC4 synthesis. Ear thickness, [125I]albumin accumulation and leukotriene C4 (LTC4) synthesis in AA-treated ears were reduced significantly by topically administered mixed lipoxygenase (LO) and cyclooxygenase inhibitors such as BW755C and phenidone. Therefore, we suggest that AA-induced ear inflammation is a suitable screen for detecting LO inhibitors in vivo.

The effects of sorbic acid in high moisture sorghum grain diets on performance of weanling swine

Three experiments were conducted with 288 weanling pigs to determine the effects of sorbic acid (SA) added to dry (DSG), high moisture (HMSG) or reconstituted (RSG) sorghum grain diets on gains and feed conversion. Dietary treatments for Exp. 1 were: DSG with and without .1% SA; HMSG with .1% SA and RSG with .1% SA. The DSG diets were fed ad libitum. The HMSG and RSG diets were mixed fresh from oxygen-limiting storage every 3 and 7 d and were also fed ad libitum. Pigs fed RSG diets consumed more feed than those fed HMSG diets (P less than .08). Performance was similar between pigs fed DSG diets without or with SA. Dietary treatments for Exp. 2 and 3 consisted of sorghum grains reconstituted to two moisture contents (MC), with additions of either 0, .05 or .1% SA. The diets were mixed fresh from oxygen-limiting storage every 7 d and fed ad libitum. In Exp. 2 and 3, pigs fed the higher MC diets were more efficient in feed conversion (P less than .03) than those fed the lower MC diets. In Exp. 3, a quadratic response (P less than .04) for average daily gain and average daily feed intake was observed for the main effect of SA. Feed efficiency improved (P less than .05) in a linear fashion as SA levels were increased in the diets. The results of these experiments indicate that weanling pigs may be fed HMSG or RSG without adverse effects on pig performance. Inconsistencies in pig response to SA were observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Synthesis of [[(naphthalenylmethoxy)- and [[(quinolinylmethoxy)phenyl]amino]oxoalkanoic acid esters. A novel series of leukotriene D4 antagonists and 5-lipoxygenase inhibitors

A series of novel [[(naphthalenylmethoxy)- and [[(quinolinylmethoxy)phenyl]amino]oxoalkanoic acid esters have been prepared. These compounds were tested as inhibitors of rat polymorphonuclear leukocyte (PMN) 5-lipoxygenase (LO) in vitro and as inhibitors of ovalbumin (OA) and leukotriene D4 (LTD4) induced bronchospasm in the guinea pig (GP) in vivo. Many naphthalenyl compounds were potent inhibitors of 5-LO, and several quinolinyl compounds were potent inhibitors of LTD4-mediated bronchospasms in the GP. The most potent naphthalenyl compound, 4-[[3-(2-naphthalenylmethoxy)phenyl]hydroxyamino]-4-oxobutanoic acid, methyl ester (6v), had an IC50 of 0.6 microM in the 5-LO assay. The most potent compound in vivo, 4-[[3-(2-quinolinylmethoxy)phenyl]hydroxyamino]-4-oxobutanoic acid, methyl ester (6e), had ED50's of 3.3 mg/kg and 27.4 mg/kg (intraduodenally) against LTD4- and OA-induced bronchospasm, respectively. When tested as an antagonist of LTD4-induced contraction of isolated GP tracheal spiral strips, 6e was shown to be a competitive inhibitor with a pKB value of 5.33.

Effect of dry, high-moisture and reconstituted normal and high-lysine corn diets and particle size on energy and nitrogen metabolism in growing swine

Two metabolism studies were conducted with 24 (Exp. 1) and 36 (Exp. 2) crossbred barrows (initial weight 35 kg) to determine the effect of corn type--normal corn (NC) and high-lysine corn (HLC)--and storage method--dry (D), high-moisture (HM) and reconstituted (RC)--on energy and N digestibility. Diets fed in Exp. 1 were: 1, NC-soybean meal formulated at .78% lysine (dry matter basis); 2, HLC-soybean meal containing the same amount of corn as diet 1 (.87% lysine); 3, HLC-soybean meal with the same lysine level as diet 1. In Exp. 1, dry matter, energy and N digestibilities were not different between corn types or lysine levels (P greater than .16). These results indicate that energy and N digestibility of HLC in typical diets for growing swine are similar to those for NC diets when both are balanced on a lysine basis. Also, replacing NC with HLC on an equal-weight basis did not affect energy and N digestibility. In Exp. 2 six diets balanced on an isonitrogenous and dry-matter basis were tested. Normal corn and HLC diets, which had been stored by three different methods (D, HM and RC) were arranged in a 2 X 3 factorial plan. There were no differences between corn types in dry matter, energy and N digestibilities. The HM and RC treatments had larger particle sizes than the dry corn diets. For diets balanced on an isonitrogenous basis, dry corn storage improved energy digestibility (P less than .10). Reconstitution appeared to improve energy balance and N digestibility of HLC, while HM storage improved energy balance and N digestibility of NC.

Novel 1,3-bis(aryloxy)propanes as leukotriene D4 antagonists

The synthesis and structure-activity relationships of a number of 1,3-bis(aryloxy)propanes, which are in vivo antagonists of LTD4 in the guinea pig, are described. One of these compounds, 4 (Wy-44,329), was not only approximately equipotent with the standard 1 (FPL 55712) in the LTC4 (ID50 = 0.17 and 0.23 mg/kg iv, respectively) and LTD4 (ID50 = 0.11 and 0.15 mg/kg iv, respectively) challenge models but also possessed greater potency in the ovalbumin challenge model (ID50 = 0.47 mg/kg and 4.1 mg/kg iv, respectively) and a longer duration of action. This compound was a competitive LTD4 antagonist on guinea pig ileum (pA2 = 9.4) and possessed mediator release (rat PCA, ID50 = 0.26 mg/kg iv) and 5-lipoxygenase (IC50 = 32 microM vs. 5-HETE) inhibitory activities.